쎌바이오텍

049960KOSDAQ기초 의약물질 제조업

67.2 / 100

Reference Date: 2026-06-10

Financial Score31.5 / 40

News Sentiment14.7 / 25

Momentum11.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly up 3.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Sebaitech operates in three main areas: probiotics, microbiome, and anti-cancer drug development. It maintains the top position in South Korea's probiotic exports and is developing functional foods for atopic dermatitis and menopausal symptoms through its microbiome business. The company also aims to create probiotic-based therapies for ulcerative colitis and colorectal cancer.

Number of Employees

123people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

11.13Industry Average 27.718.0Point

Half of industry avg (excellent)

PBR

1.18Industry Average 1.745.5Point

Lower than industry avg (good)

ROE

7.92Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

0.06Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼0.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.0% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.8% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 1Neutral 3Negative 0Average Sentiment Score 58.8

Positive
듀오락, 유산균 효과 결정 핵심 요소로…'이것' 제시
쎌바이오텍의 듀오락 유산균 브랜드가 장까지의 유산균 이동 효율성 향상을 위한 코팅 기술의 중요성을 강조하는 인포그래픽을 공개하여 긍정적인 시장 반응을 유도.
Neutral
듀오락, 유산균 ‘균손실’ 과정 알린다 “보장균수보다 중요한 건 코....
듀오락의 유산균 코팅 기술 발표는 시장 동향에 영향을 미칠 수 있으나, 직접적인 쎌바이오텍 영향은 제한적.
Neutral
듀오락, 균손실 개념 제시…"유산균 선택기준 이것"
듀오락의 새로운 광고 캠페인 공개로 인해 쎌바이오텍과 직접적인 연관성이 적어 중립적인 평가.

Detailed Momentum

52-week position6.0Point

52w upper range (75%)

Current 16,460Won52-week high 18,11052-week low 11,500

1-month return4.0Point

1m +3.78% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-15